ECATERINA SCĂRLĂTESCU

Dr. Scărlătescu Ecaterina graduated from the "Carol Davila" University of Medicine and Pharmacy Bucharest in 2005 and trained in Anesthesia and Intensive Care Medicine at Fundeni Clinical Institute, Bucharest, Romania. After the residency, she continued to work in the Department of Anaesthesiology and Intensive Care III at Fundeni Clinical Institute where she is now appointed as Consultant. She is involved in clinical work (visceral and thoracic surgery, liver transplantation, care of the medical and surgical intensive care patients – both adults and pediatric patients), but also in research and training activities.

Since 2016 she is a lecturer in international courses and spin-off seminars and workshops on Severe Bleeding Management – Patient Blood Management. Since October 2021 she has been appointed as Assistant Professor at "Carol Davila" University of Medicine and Pharmacy, Department of Anesthesia and Intensive Care Medicine.

She received the Reach-the-World Fellowship (RTW) from the International Society on Hemostasis and Thrombosis in 2017 and trained for three months at Maastricht University Medical Center in Maastricht, the Netherlands on the topics of anticoagulant management in patients on extracorporeal life support and the use of thrombin generation tests.

In 2018 she completed her Ph.D. with the thesis "The complex assessment of coagulation disturbances in early sepsis and their prognostic significance".

Since 2018 she served as a Co-Chair in the DIC Subcommittee of the International Society on Hemostasis and Thrombosis (ISTH) and in 2020 she was appointed Chair of the DIC Subcommittee.

Since 2018 she has received 2 research grants from the International Society on Thrombosis and Haemostasis (ISTH) for the study of coagulopathy in septic patients and disseminated intravascular coagulation (DIC) in cirrhotic patients. Major research interests and current research projects include: the study of sepsis-associated coagulopathy and sepsis-induced DIC, the assessment of hemostasis in acute liver failure and end-stage liver diseases, the assessment of coagulopathy in cirrhotic patients with sepsis and septic shock, bleeding management in liver transplantation, antithrombotic therapy monitoring in liver cirrhosis patients, extracorporeal blood purification therapies for supportive treatment of acute liver failure patients and as bridging to liver transplantation, the diagnostic and clinical implications of cirrhotic cardiomyopathy and postreperfusion syndrome during liver transplantation.